Autoimmune/Inflammatory syndrome induced by adjuvants (ASIA): Neuromyelitis optica spectrum disorder after BBIBP-Cor-V vaccine, case report
- Sandra Berrú-Villalobos,
- Ricardo Otiniano-Sifuentes,
- ,
- Víctor Osorio-Marcatinco,
- Erik Guevara-Silva,
- María Meza-Vega
- docencia y atención especializada en epilepsia,
- Universidad Peruana Cayetano Heredia,
- ,
- Basic Research Center in Dementia and Central Nervous System Demyelinating Diseases,
- Atlantic Senior Fellow at Global Brain Health Institute,
- Universidad Nacional Mayor de San Marcos
Open access
Publication Information
Output type
Original language
EnglishArticle number
100107Journal (Volume, Issue Number)
Neuroimmunology Reports (Volume 2)Publication milestones
- Published - 01/2022
Publication status
Publication IDs
- Scopus: 85149605982
Abstract
Background: Recently the term Autoimmune/Inflammatory Syndrome induced by Adjuvants has been proposed to describe different clinical conditions, among them post-vaccinal phenomena like demyelinating diseases. Objective: We aim to add knowledge on the possible association of vaccines and the development of demyelinating diseases. Case report: We present the case of a 38-year-old female that developed a brainstem syndrome after vaccination with COVID-19 BBIBP-CorV Sinopharm Vaccine. The final diagnosis after extensive work-out was Neuromyelitis Optica spectrum disorder with positive Aquaporin 4 positive antibodies; and long-term treatment with Rituximab was initiated. Conclusion: Since we are facing a large-scale vaccination, professionals should be aware of the presence of demyelinating diseases as adverse events for COVID-19 vaccine.
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
